Back to search
Non-Germline BRCA Mutated Ovarian Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Germline BRCA Mutated Ovarian Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Germline BRCA Mutated Ovarian Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial studies how well talazoparib works in treating patients with cancers that have returned after a period of improvement, do not respond to tre…
The purpose of the study is to assess the efficacy and safety of single-agent olaparib as a maintenance treatment in patients with relapsed High Grade Serous Ov…
This is an open label, single arm, multi-center study to assess the efficacy and safety of the combination of cediranib and olaparib tablets in platinum-resista…